Science 37 Uses the Metasite to Support Clinical Trial in Rare Neurodegenerative Disease

An industry leading pharmaceutical company implemented the Science 37’s Metasite to reduce patient patient burden and accelerate trial timelines.

Learn how the Metasite expanded reach beyond site confines - bringing both neurological assessments and pharmacokinetic blood draws from the comfort of home.